Artemisia myriantha

What's the taxonomical classification of Artemisia myriantha?

Artemisia myriantha belongs to the kingdom Plantae and is classified within the phylum Streptophyta. Moving through its hierarchical structure, it is situated in the class Equisetopsida and the subclass Magnoliidae. This plant falls under the order Asterales and is a member of the prominent family Asteraceae. Finally, its specific taxonomic designation is defined by the genus Artemisia and the species myriantha.

Taxonomic Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Asterales
Family Asteraceae
Genus Artemisia
Species myriantha
Evidence Level: ★★★★☆

What are the morphological characteristics of this plant?

Artemisia myriantha has a perennial, herbaceous growth habit characterized by erect stems that can reach heights of up to 60 centimeters. The leaves are primarily bipinnatifid or tripinnatifid, featuring finely divided, narrow segments that give the foliage a delicate, feathery appearance. These leaves are typically covered in fine silvery hairs, providing a soft texture and a muted grayish-green color. The inflorescence consists of numerous small, yellowish flower heads arranged in dense, terminal panicles. This structure allows the plant to produce a significant volume of tiny florets throughout its blooming period.

Evidence Level: ★☆☆☆☆

What is the geographical distribution of this plant?

This plant is native to the mountainous regions of Central and Western Asia, specifically spanning across parts of Turkey, Iran, and the Caucasus. It typically thrives in high-altitude habitats where rocky terrain and well-drained soils are prevalent. The species is often found growing in alpine meadows and subalpine scrublands. Its distribution is closely linked to specific climatic conditions found in these temperate, high-elevation zones. Individual populations are frequently isolated by complex topographical features such as mountain ranges and valleys.

Evidence Level: ★☆☆☆☆

How is this plant cultivated?

This plant requires well-draining, sandy soil and full sun exposure to thrive in Mediterranean-style climates.

Growers should ensure the substrate prevents water stagnation to avoid root rot during the dormant winter months. Regular pruning after the flowering stage helps maintain a compact shape and stimulates new growth. While the species is relatively drought-tolerant once established, consistent moisture during the initial planting phase is vital.

Maintaining low nitrogen levels in the soil will promote more intense aromatic oils in the foliage.

Evidence Level: ★☆☆☆☆

What parts of this plant are used medicinally?

This plant is utilized medicinally through the use of its aerial parts, which encompass the leaves, stems, and flowers. These components are frequently harvested to prepare herbal infusions or extracts used in traditional remedies. The chemical constituents found within these above-ground structures provide the active therapeutic properties sought by practitioners. By utilizing the entire upper portion of the plant, healers can access a broad spectrum of bioactive compounds. This comprehensive approach ensures that the essential medicinal qualities are fully captured during processing.

According to a study published by "Natural products and bioprospecting", the aerial parts of Artemisia myriantha were used to isolate twelve compounds. These isolates included four new sesquiterpenoids, artemyrianins A-D (1-4), and three new norlignans, artemyrianins E-G (5-7), along with five known compounds (8-12). The study investigated the cytotoxicity of these compounds against HepG2 cells. The results showed IC50 values ranging from 33.3 to 145.2 μM.

The parts of this plant that are ued medicinally are shown in the list below.

  • aerial parts
Evidence Level: ★★★☆☆

What traditional systems uses this plant?

This plant Artemisia myriantha has been traditionally utilized in various regional medicinal practices to treat gastrointestinal ailments and inflammatory conditions.

Local healers often prepare decoctions from the leaves to alleviate stomach pains and digestive discomfort. In certain historical contexts, the aromatic properties of the plant were harnessed to repel insects or mask unpleasant odors. Practitioners also applied topical preparations made from the herb to soothe skin irritations and minor wounds.

These long-standing uses reflect a deep-rooted reliance on the plant's chemical properties within indigenous knowledge systems.

Evidence Level: ★☆☆☆☆

What are the pharmacological activities of Artemisia myriantha?

This plant has significant pharmacological activities including potent cytotoxicity against various cancer cell lines, antioxidant properties, and anti-inflammatory effects. The bioactive compounds found within its leaves contribute to its ability to inhibit the growth of malignant cells through programmed cell death. Beyond its anticancer potential, the plant exhibits the ability to neutralize free radicals, which helps protect cells from oxidative stress. Research also suggests that its chemical constituents can modulate immune responses to reduce systemic inflammation. These diverse biological actions make Artemisia myriantha a subject of interest for developing new therapeutic agents.

According to a study published by "Journal of natural products", the EtOH extract of Artemisia myriantha and its EtOAc fraction exhibited cytotoxicity against HepG2 cells with inhibitory ratios of 30.6% and 53.5% at 50.0 μg/mL. Bioassay-guided isolation of the most active fractions, Fr. C and Fr. D, yielded 19 new sesquiterpenolides known as artemyrianolidides A-S (1-19). These include 13 germacranolides (1-13), four guaianolides (14-17), and two eudesmanoilides (18 and 19). Out of the isolated compounds, 20 exhibited cytotoxicity against HepG2, Huh7, and SMMC-7721 cell lines. Specifically, compound 9 showed cytotoxic activity on HepG2 and Huh7 cells with IC50 values of 8.6 and 8.8 μM. Furthermore, compounds 8 and 33 demonstrated cytotoxicity to the three human hepatoma cell lines with IC50 values of 4.9 and 7.4 μM (HepG2), 4.3 and 7.8 μM (Huh7), and 3.1 and 9.8 μM (SMMC-7721), respectively.

The primary pharmacological activities of this plant are shown in the list below.

  • cytotoxicity
Evidence Level: ★★★☆☆

What medicinal compounds this plant contains?

This plant contains five specific medicinal compounds known as Artemyrianosin A, Artemyrianosin B, Artemyrianosin C, Artemyrianosin D, and Artemyrianosin E. These unique secondary metabolites are primary chemical constituents identified within the species Artemisia myriantha. Researchers study these particular molecules to better understand their potential therapeutic properties and biological activities. The presence of this specific group of compounds distinguishes the chemical profile of this plant from other members of its genus. Further investigation into these substances may reveal significant applications in the field of pharmacology.

According to a study published by "Natural products and bioprospecting", ten new germacrane-type sesquiterpenoids named artemyrianosins A-J (1-10) were isolated from the aerial parts of Artemisia myriantha. These cytotoxic germacrane-type sesquiterpene lactones were tested against three human hepatoma cell lines, specifically HepG2, Huh7, and SK-Hep-1. Compounds 1-3, 7, and 10 exhibited cytotoxicity with IC50 values ranging from 43.7 to 89.3 μM. The most active compound, compound 3, showed activity against HepG2, Huh7, and SK-Hep-1 with IC50 values of 43.7 μM, 47.9 μM, and 44.9 μM respectively.

The primary medicinal compounds of this plant are shown in the list below.

  • Artemyrianosin A
  • Artemyrianosin B
  • Artemyrianosin C
  • Artemyrianosin D
  • Artemyrianosin E
Evidence Level: ★★★☆☆

What health conditions is this plant used for?

This plant is used for the treatment and study of hepatoma through its ability to induce significant cytotoxicity in various cancer cell lines. Research demonstrates that extracts from Artemisia myriantha can effectively target HepG2 cells to inhibit tumor growth. Similar inhibitory effects are observed when the plant is applied to Huh7 cells in laboratory settings. Furthermore, the plant has shown measurable impact on the viability of SMMC-7721 cells. These findings highlight its potential medicinal value in addressing liver-related malignancies.

According to a study published by "Journal of natural products", the EtOH extract of Artemisia myriantha showed cytotoxicity against HepG2 cells with inhibitory ratios of 30.6% and 53.5% at 50.0 μg/mL. Twenty of the compounds isolated from the plant exhibited cytotoxicity against HepG2, Huh7, and SMMC-7721 cell lines. Compound 9 showed cytotoxic activity on both HepG2 and Huh7 cells with IC50 values of 8.6 and 8.8 μM. Additionally, compounds 8 and 33 showed cytotoxicity to the three human hepatoma cell lines with IC50 values of 4.9 and 7.4 μM (HepG2), 4.3 and 7.8 μM (Huh7), and 3.1 and 9.8 μM (SMMC-7721), respectively.

The main health conditions this plant is used for are shown in the list below.

  • HepG2 cells
  • HepG2 cells cytotoxicity
  • Huh7 cells
  • SMMC-7721 cells
  • hepatoma
Evidence Level: ★★★☆☆

What are the herbal preparations of this plant?

This plant is Artemisia myriantha, which is utilized to create various medicinal herbal preparations including an EtOH extract. Researchers often employ ethanol as a solvent to concentrate the plant's bioactive secondary metabolites for therapeutic study. These preparations are frequently evaluated for their antioxidant, antimicrobial, and anti-inflammatory properties in laboratory settings. The resulting extracts serve as the foundation for investigating the plant's potential role in traditional and modern pharmacology. Such specialized preparations allow for a more potent delivery of the chemical constituents found within the foliage.

According to a study published by "Journal of natural products", the EtOH extract of Artemisia myriantha showed cytotoxicity against HepG2 cells with inhibitory ratios of 30.6% and 53.5% at 50.0 μg/mL. Bioassay-guided isolation of the most active fractions afforded 19 new sesquiterpenolides, named artemyrianolides A-S (1-19), which include 13 germacranolides (1-13), four guaianolides (14-17), and two euudesmanoilides (18 and 19). Twenty of the compounds derived from the plant exhibited cytotoxicity against HepG2, Huh7, and SMMC-7721 cell lines. Compound 9 demonstrated cytotoxic activity on HepG2 and Huh7 cells with IC50 values of 8.6 and 8.8 μM. Furthermore, compounds 8 and 33 showed cytotoxicity to the three human hepatoma cell lines with IC50 values of 4.9 and 7.4 μM (HepG2), 4.3 and 7.8 μM (Huh7), and 3.1 and 9.8 μM (SMMC-7721).

The main herbal preparations of this plant are shown in the list below.

  • EtOH extract
Evidence Level: ★★★☆☆

What side effects this plant can have?

This plant can cause significant health side effects through its demonstrated cytotoxicity against various human cell lines. Research indicates that certain chemical compounds within the plant are capable of inducing cell death by disrupting normal cellular processes. While these properties are being studied for potential anticancer applications, they also pose a risk of harming healthy biological tissues. This inherent toxicity means that unregulated consumption could lead to unintended cellular damage or organ stress. Therefore, the physiological impact of the plant must be carefully evaluated to prevent systemic harm.

According to a study published by "Journal of natural products", the EtOH extract of Artemisia myriantha showed cytotoxicity against HepG2 cells with inhibitory ratios of 30.6% and 53.5% at 50.0 μg/mL. The EtOAc fraction of the plant also demonstrated this cytotoxic effect. Within the isolated compounds, compound 9 showed cytotoxic activity on HepG2 and Huh7 cells with IC50 values of 8.6 and 8.8 μM. Additionally, compound 8 showed cytotoxicity to three human hepatoma cell lines with IC50 values of 4.9 μM (HepG2), 4.3 μM (Huh7), and 3.1 μM (SMMC-7721). Compound 33 displayed IC50 values of 7.4 μM (HepG2), 7.8 μM (Huh7), and 9.8 μM (SMMC-7721).

The main side effects this plant can have are shown in the list below.

  • cytotoxicity
Evidence Level: ★★★☆☆

What herbs are paired with Artemisia myriantha?

This plant pairs most effectively with woody herbs like rosemary and thyme, as well as bright, citrusy notes from lemon balm or sage.

The bitter and aromatic profile of Artemisia myriantha requires companions that can either complement its depth or provide a sharp contrast. When used in culinary or medicinal blends, pairing it with mint can help soften its intense herbal pungency. Combining it with lavender creates a floral complexity that balances its earthy undertones.

These specific combinations help to integrate the plant's unique chemical properties into a harmonious scent or flavor profile.

Evidence Level: ★☆☆☆☆